Arrow Mark Colorado Holdings LLC Taysha Gene Therapies, Inc. Transaction History

Arrow Mark Colorado Holdings LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$19.29 - $26.38 $2.23 Million - $3.05 Million	-115,723 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$20.3 - $31.75 $252,755 - $395,319	-12,451 Reduced 9.71%	115,723 $2.35 Million
Q4 2020 Feb 16, 2021	SELL	$19.14 - $28.13 $3.8 Million - $5.59 Million	-198,688 Reduced 60.79%	128,174 $3.4 Million
Q3 2020 Nov 16, 2020	BUY	$22.4 - $24.47 $7.32 Million - $8 Million	326,862 New	326,862 $7.32 Million

117

136M

25.9K

24K

Ticker TSHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,359,500
Market Cap $85.1M
Description
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.